News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Goadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

Articles by Goadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

Study Summary: STRIVE Subgroup Analysis - Efficacy and Safety of Erenumab in Patients With Prior Preventive Treatment Failure

ByGoadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

June 5th 2019

Study Summary: STRIVE

ByGoadsby PJ, Reuter U, Hallstr&#246, m Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017, 377(22):2123-2132. doi: 10.1056/NEJMoa1705848.

May 9th 2018

Latest Updated Articles

Study Summary: STRIVE
May 9th 2018
Study Summary: STRIVE Subgroup Analysis - Efficacy and Safety of Erenumab in Patients With Prior Preventive Treatment Failure
June 5th 2019

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access